{"pmid":32441869,"title":"Good deeds and cheap marketing-The food industry in the times of COVID-19.","text":["Good deeds and cheap marketing-The food industry in the times of COVID-19.","The consumption of ultra-processed foods is one of the main drivers of the global obesity and non-communicable disease (NCDs) epidemic(1) . It is well known that obesity is associated with a low intensity chronic inflammatory state that creates a suboptimal immune response,(2) which negatively affects the prognosis of COVID-19(3) . The epidemic of obesity and COVID-19 can be viewed as a syndemic as they negatively interact with one another to exacerbate the course of disease, leading to greater complications and severe illness. Together, they create a simultaneous and significant burden on the health system(4) . Thus, an in-depth analysis on the food industry's role in this pandemic and in our society is necessary.","Obesity (Silver Spring)","White, Mariel","Nieto, Claudia","Barquera, Simon","32441869"],"abstract":["The consumption of ultra-processed foods is one of the main drivers of the global obesity and non-communicable disease (NCDs) epidemic(1) . It is well known that obesity is associated with a low intensity chronic inflammatory state that creates a suboptimal immune response,(2) which negatively affects the prognosis of COVID-19(3) . The epidemic of obesity and COVID-19 can be viewed as a syndemic as they negatively interact with one another to exacerbate the course of disease, leading to greater complications and severe illness. Together, they create a simultaneous and significant burden on the health system(4) . Thus, an in-depth analysis on the food industry's role in this pandemic and in our society is necessary."],"journal":"Obesity (Silver Spring)","authors":["White, Mariel","Nieto, Claudia","Barquera, Simon"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32441869","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.1002/oby.22910","keywords":["covid-19","obesity","food industry"],"weight":0,"_version_":1667523504719790080,"score":9.490897,"similar":[{"pmid":32459524,"title":"Obesity and COVID-19: Immune and metabolic derangement as a possible link to adverse clinical outcomes.","text":["Obesity and COVID-19: Immune and metabolic derangement as a possible link to adverse clinical outcomes.","Recent reports have shown a strong association between obesity and the severity of COVID-19 infection, even in the absence of other co-morbidities. After infecting the host cells, SARS-CoV-2 may cause a hyper-inflammatory reaction through the excessive release of cytokines, a condition known as \"cytokine storm\", while inducing lymphopenia and a disrupted immune response. Obesity is associated with chronic low-grade inflammation and immune dysregulation, but the exact mechanisms through which it exacerbates COVID-19 infection are not fully clarified. The production of increased amounts of cytokines such as TNF-alpha, IL-1, IL-6 and MCP-1 lead to oxidative stress and defective function of innate and adaptive immunity, while the activation of NLRP3 inflammasome seems to play a crucial role in the pathogenesis of the infection. Endothelial dysfunction and arterial stiffness could favor the recently discovered infection of the endothelium by SARS-CoV-2, while alterations in cardiac structure and function and the pro-thrombotic microenvironment in obesity could provide a link for the increased cardiovascular events in these patients. The successful use of anti-inflammatory agents such as IL-1 and IL-6 blockers in similar hyper-inflammatory settings like that of rheumatoid arthritis has triggered the discussion of whether such agents could be administrated in selected patients with COVID-19 disease.","Am J Physiol Endocrinol Metab","Korakas, Emmanouil","Ikonomidis, Ignatios","Kousathana, Foteini","Balampanis, Konstantinos","Kountouri, Aikaterini","Raptis, Athanasios","Palaiodimou, Lina","Kokkinos, Alexander","Lambadiari, Vaia","32459524"],"abstract":["Recent reports have shown a strong association between obesity and the severity of COVID-19 infection, even in the absence of other co-morbidities. After infecting the host cells, SARS-CoV-2 may cause a hyper-inflammatory reaction through the excessive release of cytokines, a condition known as \"cytokine storm\", while inducing lymphopenia and a disrupted immune response. Obesity is associated with chronic low-grade inflammation and immune dysregulation, but the exact mechanisms through which it exacerbates COVID-19 infection are not fully clarified. The production of increased amounts of cytokines such as TNF-alpha, IL-1, IL-6 and MCP-1 lead to oxidative stress and defective function of innate and adaptive immunity, while the activation of NLRP3 inflammasome seems to play a crucial role in the pathogenesis of the infection. Endothelial dysfunction and arterial stiffness could favor the recently discovered infection of the endothelium by SARS-CoV-2, while alterations in cardiac structure and function and the pro-thrombotic microenvironment in obesity could provide a link for the increased cardiovascular events in these patients. The successful use of anti-inflammatory agents such as IL-1 and IL-6 blockers in similar hyper-inflammatory settings like that of rheumatoid arthritis has triggered the discussion of whether such agents could be administrated in selected patients with COVID-19 disease."],"journal":"Am J Physiol Endocrinol Metab","authors":["Korakas, Emmanouil","Ikonomidis, Ignatios","Kousathana, Foteini","Balampanis, Konstantinos","Kountouri, Aikaterini","Raptis, Athanasios","Palaiodimou, Lina","Kokkinos, Alexander","Lambadiari, Vaia"],"date":"2020-05-28T11:00:00Z","year":2020,"_id":"32459524","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1152/ajpendo.00198.2020","keywords":["covid-19","obesity","arterial stiffness","cytokines","immune system"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667967699029852161,"score":152.23007},{"pmid":32438620,"title":"COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation.","text":["COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation.","The novel coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has engulfed the world, affecting more than 180 countries. As a result, there has been considerable economic distress globally and a significant loss of life. Sadly, the vulnerable and immunocompromised in our societies seem to be more susceptible to severe COVID-19 complications. Global public health bodies and governments have ignited strategies and issued advisories on various handwashing and hygiene guidelines, social distancing strategies, and, in the most extreme cases, some countries have adopted \"stay in place\" or lockdown protocols to prevent COVID-19 spread. Notably, there are several significant risk factors for severe COVID-19 infection. These include the presence of poor nutritional status and pre-existing noncommunicable diseases (NCDs) such as diabetes mellitus, chronic lung diseases, cardiovascular diseases (CVD), obesity, and various other diseases that render the patient immunocompromised. These diseases are characterized by systemic inflammation, which may be a common feature of these NCDs, affecting patient outcomes against COVID-19. In this review, we discuss some of the anti-inflammatory therapies that are currently under investigation intended to dampen the cytokine storm of severe COVID-19 infections. Furthermore, nutritional status and the role of diet and lifestyle is considered, as it is known to affect patient outcomes in other severe infections and may play a role in COVID-19 infection. This review speculates the importance of nutrition as a mitigation strategy to support immune function amid the COVID-19 pandemic, identifying food groups and key nutrients of importance that may affect the outcomes of respiratory infections.","Nutrients","Zabetakis, Ioannis","Lordan, Ronan","Norton, Catherine","Tsoupras, Alexandros","32438620"],"abstract":["The novel coronavirus disease (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has engulfed the world, affecting more than 180 countries. As a result, there has been considerable economic distress globally and a significant loss of life. Sadly, the vulnerable and immunocompromised in our societies seem to be more susceptible to severe COVID-19 complications. Global public health bodies and governments have ignited strategies and issued advisories on various handwashing and hygiene guidelines, social distancing strategies, and, in the most extreme cases, some countries have adopted \"stay in place\" or lockdown protocols to prevent COVID-19 spread. Notably, there are several significant risk factors for severe COVID-19 infection. These include the presence of poor nutritional status and pre-existing noncommunicable diseases (NCDs) such as diabetes mellitus, chronic lung diseases, cardiovascular diseases (CVD), obesity, and various other diseases that render the patient immunocompromised. These diseases are characterized by systemic inflammation, which may be a common feature of these NCDs, affecting patient outcomes against COVID-19. In this review, we discuss some of the anti-inflammatory therapies that are currently under investigation intended to dampen the cytokine storm of severe COVID-19 infections. Furthermore, nutritional status and the role of diet and lifestyle is considered, as it is known to affect patient outcomes in other severe infections and may play a role in COVID-19 infection. This review speculates the importance of nutrition as a mitigation strategy to support immune function amid the COVID-19 pandemic, identifying food groups and key nutrients of importance that may affect the outcomes of respiratory infections."],"journal":"Nutrients","authors":["Zabetakis, Ioannis","Lordan, Ronan","Norton, Catherine","Tsoupras, Alexandros"],"date":"2020-05-23T11:00:00Z","year":2020,"_id":"32438620","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.3390/nu12051466","keywords":["covid-19","sars-cov-2","anti-inflammatory","coronavirus","infection","inflammation","noncommunicable diseases","nutrition","vitamin c","vitamin d","zinc"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667535119496249345,"score":149.27966},{"pmid":32387864,"title":"SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects.","text":["SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects.","BACKROUND AND AIMS: According to the World Obesity Federation, \"obesity-related conditions seem to worsen the effect of Covid-19 (SARS-CoV-2)\"; additionally the Centres for Disease Control and Prevention reported that \"people with heart disease and diabetes are at higher risk of SARS-CoV-2 complications and that severe obesity poses a higher risk for severe illness\". Recent reports have shown elevated levels of cytokines due to increased inflammation in patients with SARS-CoV-2 disease. On the other hand, obesity represents a state of low-grade inflammation, with various inflammatory products directly excreted by adipose tissue. In this concise report we aimed to assess common elements of obesity and SARS-CoV-2 infection. METHODS: Pubmed search on obesity and SARS-CoV-2 infection. RESULTS: We present \"mechanistic\" obesity-related problems that aggravate SARS-CoV-2 infection as well as tentative inflammatory/metabolic links between these diseases. CONCLUSION: Obesity and SARS-CoV-2 share common elements of the inflammatory process (and possibly also metabolic disturbances), exacerbating SARS-CoV-2 infection in the obese.","Diabetes Metab Syndr","Michalakis, Konstantinos","Ilias, Ioannis","32387864"],"abstract":["BACKROUND AND AIMS: According to the World Obesity Federation, \"obesity-related conditions seem to worsen the effect of Covid-19 (SARS-CoV-2)\"; additionally the Centres for Disease Control and Prevention reported that \"people with heart disease and diabetes are at higher risk of SARS-CoV-2 complications and that severe obesity poses a higher risk for severe illness\". Recent reports have shown elevated levels of cytokines due to increased inflammation in patients with SARS-CoV-2 disease. On the other hand, obesity represents a state of low-grade inflammation, with various inflammatory products directly excreted by adipose tissue. In this concise report we aimed to assess common elements of obesity and SARS-CoV-2 infection. METHODS: Pubmed search on obesity and SARS-CoV-2 infection. RESULTS: We present \"mechanistic\" obesity-related problems that aggravate SARS-CoV-2 infection as well as tentative inflammatory/metabolic links between these diseases. CONCLUSION: Obesity and SARS-CoV-2 share common elements of the inflammatory process (and possibly also metabolic disturbances), exacerbating SARS-CoV-2 infection in the obese."],"journal":"Diabetes Metab Syndr","authors":["Michalakis, Konstantinos","Ilias, Ioannis"],"date":"2020-05-11T11:00:00Z","year":2020,"_id":"32387864","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.dsx.2020.04.033","keywords":["coronavirus","glucose","human","infection","inflammation","obesity"],"locations":["obese"],"topics":["Mechanism"],"weight":1,"_version_":1666428892678717440,"score":148.64005},{"pmid":32314871,"title":"Targeting the Adipose Tissue in COVID-19.","text":["Targeting the Adipose Tissue in COVID-19.","The WHO considers non-communicable diseases (NCDs), such as obesity, a major risk factor for becoming seriously ill with 2019 novel coronavirus (COVID-19) (1). A study by the UK Intensive Care National Audit and Research Centre indicates that two thirds of people who developed serious or fatal COVID-19-related complications were overweight or obese (2). The report includes data from all COVID-19 admissions in intensive care units in the UK until midnight, March 19, 2020. The study shows that almost 72 % of those in critical care units are either overweight or with obesity suggesting the impact of obesity in seriously ill COVID-19 patients.","Obesity (Silver Spring)","Malavazos, Alexis Elias","Corsi Romanelli, Massimiliano Marco","Bandera, Francesco","Iacobellis, Gianluca","32314871"],"abstract":["The WHO considers non-communicable diseases (NCDs), such as obesity, a major risk factor for becoming seriously ill with 2019 novel coronavirus (COVID-19) (1). A study by the UK Intensive Care National Audit and Research Centre indicates that two thirds of people who developed serious or fatal COVID-19-related complications were overweight or obese (2). The report includes data from all COVID-19 admissions in intensive care units in the UK until midnight, March 19, 2020. The study shows that almost 72 % of those in critical care units are either overweight or with obesity suggesting the impact of obesity in seriously ill COVID-19 patients."],"journal":"Obesity (Silver Spring)","authors":["Malavazos, Alexis Elias","Corsi Romanelli, Massimiliano Marco","Bandera, Francesco","Iacobellis, Gianluca"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314871","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1002/oby.22844","keywords":["ace2","covid-19","adipose tissue: dpp4"],"locations":["GBR"],"countries":["United Kingdom"],"countries_codes":["GBR|United Kingdom"],"topics":["Treatment"],"weight":1,"_version_":1666138493464608769,"score":145.8589},{"pmid":32463562,"title":"Possible Role of Adipose Tissue and Endocannabinoid System in COVID-19 Pathogenesis: Can Rimonabant Return?","text":["Possible Role of Adipose Tissue and Endocannabinoid System in COVID-19 Pathogenesis: Can Rimonabant Return?","This is the main conclusion of a recent study describing a strong relationship between the degree of obesity and the severity of COVID-19 infection. Obesity has various negative consequences relative to the course of COVID-19, including adverse effects on lung physiology, and induces comorbidities such as type II diabetes or hypertension. However, additional mechanisms involving the low-grade inflammatory state accompanying obesity can also be suggested.","Obesity (Silver Spring)","Briand-Mesange, Fabienne","Trudel, Stephanie","Salles, Juliette","Ausseil, Jerome","Salles, Jean-Pierre","Chap, Hugues","32463562"],"abstract":["This is the main conclusion of a recent study describing a strong relationship between the degree of obesity and the severity of COVID-19 infection. Obesity has various negative consequences relative to the course of COVID-19, including adverse effects on lung physiology, and induces comorbidities such as type II diabetes or hypertension. However, additional mechanisms involving the low-grade inflammatory state accompanying obesity can also be suggested."],"journal":"Obesity (Silver Spring)","authors":["Briand-Mesange, Fabienne","Trudel, Stephanie","Salles, Juliette","Ausseil, Jerome","Salles, Jean-Pierre","Chap, Hugues"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32463562","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/oby.22916","keywords":["covid-19","adipose tissue","endocannabinoids","obesity","rimonabant"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1668079521352384514,"score":145.64024}]}